News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
382,176 Results
Type
Article (23914)
Company Profile (31)
Press Release (358226)
Multimedia
Podcasts (132)
Webinars (15)
Section
Business (118998)
Career Advice (1490)
Deals (17378)
Drug Delivery (85)
Drug Development (42350)
Employer Resources (106)
FDA (8852)
Job Trends (8521)
News (190308)
Policy (17229)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1491)
Academic (1)
Accelerated approval (24)
Adcomms (17)
Allergies (115)
Alliances (33170)
ALS (138)
Alzheimer's disease (1072)
Antibody-drug conjugate (ADC) (283)
Approvals (9182)
Artificial intelligence (456)
Autoimmune disease (181)
Automation (38)
Bankruptcy (168)
Best Places to Work (7055)
BIOSECURE Act (8)
Biosimilars (134)
Biotechnology (26)
Bladder cancer (128)
Brain cancer (39)
Breast cancer (477)
Cancer (3782)
Cardiovascular disease (318)
Career advice (1291)
Career pathing (34)
CAR-T (172)
CDC (30)
Celiac Disease (1)
Cell therapy (552)
Cervical cancer (30)
Clinical research (37328)
Collaboration (1538)
Company closure (4)
Compensation (350)
Complete response letters (33)
COVID-19 (1535)
CRISPR (73)
C-suite (585)
Cystic fibrosis (85)
Data (5326)
Decentralized trials (3)
Denatured (45)
Depression (108)
Dermatology (53)
Diabetes (407)
Diagnostics (3734)
Digital health (33)
Diversity (9)
Diversity, equity & inclusion (30)
Drug discovery (210)
Drug pricing (108)
Drug shortages (29)
Duchenne muscular dystrophy (184)
Earnings (58890)
Editorial (51)
Employer branding (13)
Employer resources (94)
Events (58424)
Executive appointments (595)
FDA (11253)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (10)
Frontotemporal dementia (27)
Funding (984)
Gene editing (151)
Generative AI (50)
Gene therapy (486)
GLP-1 (673)
Government (2467)
Grass and pollen (6)
Guidances (339)
Healthcare (10362)
HIV (60)
Huntington's disease (37)
IgA nephropathy (65)
Immunology and inflammation (168)
Immuno-oncology (65)
Indications (135)
Infectious disease (1732)
Inflammatory bowel disease (148)
Inflation Reduction Act (12)
Influenza (76)
Intellectual property (173)
Interviews (274)
IPO (8370)
IRA (31)
Job creations (1769)
Job search strategy (1042)
JPM (44)
Kidney cancer (11)
Labor market (61)
Layoffs (274)
Leadership (35)
Legal (4426)
Liver cancer (52)
Longevity (19)
Lung cancer (510)
Lymphoma (300)
Machine learning (34)
Management (38)
Manufacturing (632)
MASH (136)
Medical device (6867)
Medtech (6925)
Mergers & acquisitions (9786)
Metabolic disorders (1002)
mRNA (123)
Multiple sclerosis (134)
NASH (10)
Neurodegenerative disease (256)
Neuropsychiatric disorders (63)
Neuroscience (2017)
NextGen: Class of 2026 (3466)
Non-profit (2791)
Now hiring (11)
Obesity (448)
Opinion (227)
Ovarian cancer (121)
Pain (149)
Pancreatic cancer (175)
Parkinson's disease (222)
Partnered (22)
Patents (343)
Patient recruitment (344)
Peanut (33)
People (28385)
Pharmaceutical (9)
Pharmacy benefit managers (17)
Phase 1 (11169)
Phase 2 (15892)
Phase 3 (13341)
Pipeline (5952)
Policy (182)
Postmarket research (1644)
Preclinical (4905)
Press Release (31)
Prostate cancer (247)
Psychedelics (32)
Radiopharmaceuticals (196)
Rare diseases (684)
Real estate (2590)
Recruiting (43)
Regulatory (13510)
Reports (24)
Research institute (1388)
Resumes & cover letters (224)
Rett syndrome (24)
RNA editing (13)
RSV (54)
Schizophrenia (115)
Series A (183)
Series B (108)
Service/supplier (3)
Sickle cell disease (81)
Special edition (15)
Spinal muscular atrophy (83)
Sponsored (29)
Startups (1533)
State (1)
Stomach cancer (11)
Supply chain (67)
Tariffs (39)
The Weekly (86)
Vaccines (663)
Venture capital (64)
Weight loss (281)
Women's health (68)
Worklife (17)
Date
Today (138)
Last 7 days (524)
Last 30 days (1824)
Last 365 days (19356)
2026 (7012)
2025 (19095)
2024 (20300)
2023 (22236)
2022 (28086)
2021 (29903)
2020 (29249)
2019 (25374)
2018 (18793)
2017 (17553)
2016 (17116)
2015 (19470)
2014 (16272)
2013 (14228)
2012 (14053)
2011 (13459)
2010 (12671)
Location
Africa (560)
Alabama (64)
Alaska (4)
Arizona (147)
Arkansas (8)
Asia (22210)
Australia (3658)
California (7674)
Canada (2249)
China (799)
Colorado (362)
Connecticut (396)
Delaware (244)
Europe (52502)
Florida (1248)
Georgia (263)
Hawaii (1)
Idaho (25)
Illinois (596)
India (66)
Indiana (430)
Iowa (10)
Japan (352)
Kansas (76)
Kentucky (22)
Louisiana (14)
Maine (34)
Maryland (941)
Massachusetts (5567)
Michigan (226)
Minnesota (344)
Mississippi (2)
Missouri (68)
Montana (12)
Nebraska (9)
Nevada (89)
New Hampshire (37)
New Jersey (2449)
New Mexico (13)
New York (2158)
North Carolina (1018)
North Dakota (5)
Northern California (3780)
Ohio (201)
Oklahoma (16)
Oregon (21)
Pennsylvania (1666)
Puerto Rico (9)
Rhode Island (26)
South America (763)
South Carolina (34)
Southern California (3146)
Tennessee (147)
Texas (1231)
United States (27994)
Utah (256)
Vermont (1)
Virginia (181)
Washington D.C. (52)
Washington State (631)
West Virginia (2)
Wisconsin (67)
Wyoming (2)
382,176 Results for "heidrick and struggles".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Novo Holdings’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
Total assets under management for Novo Holdings, Novo Nordisk’s controlling shareholder, fell by more than one-third last year. The report caps off a tumultuous year for the Novo group of companies.
March 12, 2026
·
1 min read
·
Annalee Armstrong
Opinion
To Survive the Downturn, Biotechs Must Return to Basics
In the current geopolitical and capital-market uncertainty, biotechs that have not mastered the basics are the ones struggling the most. Here’s how—and why—to get the details right.
April 8, 2026
·
5 min read
·
Driscoll R. Ugarte
Manufacturing
As CGT Struggles To Scale, FDA’s New Designation Could Smooth Post-Approval Pivots
Experts suggest the FDA’s Advanced Manufacturing Technologies designation could be a lifeline for improving production processes for approved cell and gene therapies.
November 25, 2025
·
4 min read
·
Nick Paul Taylor
Government
FDA Struggles To Keep Lights On Amid Shutdown as Biopharmas Begin To See Delays
While the FDA continues to put out guidance documents and approve drugs, some companies are already reporting delays in dealings with the agency, while insiders warn of falling morale and a negative perception from the rest of the biopharma world.
October 29, 2025
·
4 min read
·
Dan Samorodnitsky
Press Releases
TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression
November 13, 2025
·
5 min read
Earnings
BMS Beats Again Despite Eliquis and Cobenfy Disappointments
Bristol Myers Squibb delivered better than expected fourth quarter earnings, but Eliquis missed expectations while Cobenfy continues to struggle with uptake.
February 5, 2026
·
2 min read
·
Dan Samorodnitsky
Sickle cell disease
Sickle Cell Gene Therapies Casgevy and Lyfgenia Still Lacking Traction 2 Years In
The first gene therapies approved to treat sickle cell disease in December 2023 are struggling on the market. But there are glimpses of forward momentum as Vertex and Genetix Bio provide updates.
February 23, 2026
·
6 min read
·
Heather McKenzie
China
Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive
Out-licensing drugs to multinational corporations is a natural step for Chinese biotechs, but the recent rise in deals is only scratching at the surface of partnership-ready biotechs in the region.
August 6, 2025
·
7 min read
·
Leslie Zhen Liang
Rare diseases
Cashing In on ‘Creative Fundamentals’ To Fund Rare Disease R&D
Rare disease drug developers struggle to survive in a biopharma investment market that prioritizes large patient populations. Initiatives like the Orphan Therapeutics Accelerator are attempting to solve what CEO Craig Martin says is not a science problem, but a math problem.
February 25, 2026
·
7 min read
·
Heather McKenzie
Mergers & acquisitions
Concentra Snags Another Struggling Biotech as Cargo Accepts $200M Buyout
The deal marks an end for CAR T company Cargo Therapeutics, which has been slashing its workforce and cutting programs since the January decision to halt its lead candidate for a certain type of aggressive large B cell lymphoma.
July 8, 2025
·
1 min read
·
Annalee Armstrong
1 of 38,218
Next
